Minding herpes and cues
Robert Siegel Human Health and Disease Monday, October 11, 2010
Robert Siegel Herpesvirus
“Creeping”
Robert Siegel Herpesviruses
Classification
- double standed DNA viruses - large, nonsegmented genome - icosahedral nucleocapsid, enveloped
Robert Siegel Virus Classification
DNA viruses
Double stranded Double stranded Single stranded Partially double stranded enveloped naked
Pox Adeno Parvo Hepadna Herpes Papilloma Anello (Mimi) Polyoma (Circo) Virus Classification
DNA viruses
Double stranded Double stranded Single stranded Partially double stranded enveloped naked
Pox Adeno Parvo Hepadna Herpes Papilloma Anello (Mimi) Polyoma (Circo)
HSV 1 and 2 VZV EBV CMV HHV6 and 7 HHV-8 (KSHV) (Herpes B – simian zoonosis)
Virology MAJOR FACTORS USED IN DIFFERENTIATING HUMAN VIRAL FAMILIES
• Type of nucleic acid (DNA vs RNA) • Nucleic acid strandedness (ds, ss, partially ds) • “Sense” of ss nucleic acid (-, +, ambisense) • Capsid morphology icosahedral, helical, complex • Envelope (present or absent) • Electron micrographic (EM) appearance • Genome segmentation • Size of virion and/or genome • Nature of gene expression (e.g. nature and number of mRNA transcripts)
Robert Siegel Virology MAJOR FACTORS USED IN DIFFERENTIATING HUMAN VIRAL FAMILIES
• Type of nucleic acid (DNA vs RNA) • Nucleic acid strandedness (ds, ss, partially ds) • “Sense” of ss nucleic acid (-, +, ambisense) • Capsid morphology icosahedral, helical, complex • Envelope (present or absent) • Electron micrographic (EM) appearance (fried egg) • Genome segmentation (number of segments = 1) • Size of virion and/or genome (big and big) • Nature of gene expression (3 kinetic classes) (e.g. nature and number of mRNA transcripts) Robert Siegel Herpesviruses
Viral morphology
- fried-egg EM appearance - virion structure (envelope, tegument, capsid, core)
Robert Siegel
The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6A and B) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Opportunistic infection • Silent infection
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Opportunistic infection • Silent infection
Robert Siegel Etymology
A word about latency
• Viral latency • Replication cycle latency • Clinical latency
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel HSV
Nomenclature
• First episode primary infection
• First episode nonprimary infection
• Recurrent infection
• Asymptomatic infection
• Asymptomatic shedding
Robert Siegel
Immunology Causes of SEVERE IMMUNODEFICIENCY:
• Genetic deficiency (inherited) • Drug induced • Cancer induced • Retroviral infection
Robert Siegel Immunology DRUG INDUCED IMMUNODEFICIENCY:
• Transplantation • Cancer Chemotherapy • Suppression of Immunological Excess
Robert Siegel Immunology Causes of SEVERE IMMUNODEFICIENCY:
• Genetic deficiency (inherited) • Drug induced • Cancer induced • Retroviral infection
Robert Siegel Immunology Additional causes of SEVERE IMMUNODEFICIENCY:
• Viral and other infections • Malnutrition • Physiological stress • Psychological factors
Robert Siegel Herpesvirus
Of cold sores and fever blisters
Robert Siegel Immunology Additional causes of SEVERE IMMUNODEFICIENCY:
• Viral and other infections • Malnutrition • Physiological stress • Psychological factors
Robert Siegel Herpesvirus
All of these are signals for reactivation
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6A and B) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel Herpes simplex infection Clinical manifestations
• herpes labialis stomatitis, gingivostomatitis (cold sore, fever blister) • herpes genitalis • herpes simplex virus pharyngitis • herpes keratitis, keratoconjunctivitis • herpetic whitlow • eczema herpeticum = Kaposi's varicelliform eruption • herpes encephalitis • herpes neonatorum • disseminated herpes simplex
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel Herpesvirus
From chickenpox to CMV
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
Robert Siegel Hallmarks of Human HERPESVIRUS Infection Virology
• Incurability • Latency • Reactivation • Ubiquity • Multiple clinical manifestations • Silent infection • Opportunistic infection
• (oncogenicity) Robert Siegel Human herpes form a group A creepy ignominious troop Distinctive hallmarks separate This noisome little gang of eight
Reactivation - coming out Ubiquity, they’re all about Latency is on the list Both inapparent, and opportunist
Add incurability Herpes for eternity Oncogenic potential too But so far shown for just a few. RDS Robert Siegel 11/14/05 Virology Viruses associated with HUMAN CANCER:
• Human T-cell lymphotropic virus type I (HTLV-1) • Epstein-Barr virus (EBV) • Human papilloma virus (HPV) • Hepatitis B virus (HBV) • Hepatitis C virus (HCV) • Kaposi’s sarcoma associated herpes (KSHV)
Robert Siegel Virology Viruses associated with HUMAN CANCER:
• Human T-cell lymphotropic virus type I (HTLV-1) • Epstein-Barr virus (EBV) • Human papilloma virus (HPV) • Hepatitis B virus (HBV) • Hepatitis C virus (HCV) • Kaposi’s sarcoma associated herpes (KSHV) • Merkel cell polyoma virus (MCV, MCpV)
• Xenotropic murine retrovirus (XMRV) Robert Siegel
Herpesvirus
Of nuns and prostitutes
Robert Siegel Herpesvirus
Of correlation and causality
Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel Viral exanthems
Classification
• Erythematous maculo-papular • Vesicular • Nonerythematous papular • Other (petechial, pustular, etc.)
Robert Siegel
Vesicular Viral Exanthems: Common Themes
• Fluid-filled lesions contain infectious virus • Highly contagious
Robert Siegel
Vesicular Viral Exanthems: Common Taxonomic Themes
Large DNA viruses
Robert Siegel HSV
Clinical
• Incubation period 5-7 days (range 2-12 days)
• In general, HSV-1 results in clinical manifestations “above the belt”
• In general, HSV-2 results in clinical manifestations “below the belt”.
• These generalizations are violated around 5-15% of the time.
• This is said to be due to “mixing and matching of mucous membranes”
• However, there are differences in tropism.
Robert Siegel
COMPARISON OF HSV-1 AND HSV-2
HSV-1 HSV-2
Nongenital Location Genital Nongenital Transmission Genital 67 DNA (Moles/100 cc 69 Small Lesion Size Larger HSV
Transmission
• Highly infectious via apposition of skin, mucous membranes, or secretions • May spread from visible lesions or as a result of asymptomatic shedding • Spread enhanced if skin is damaged (e.g. burns, eczema, diaper rash)
C. Prober HSV
Transmission
• Perinatal transmission occurs at high frequency among parturient women with primary infection. • Recurrent disease may be perinatally transmitted at a much lower frequency. • Intrauterine transmission has also been documented at a very low rate.
Robert Siegel HSV Epidemiology
• Majority of infections are asymptomatic or atypical • HSV-1 infections begin in infancy and continue throughout life • HSV-2 infections begin with onset of sexual activity and continue throughout life • Worldwide distribution with humans as the only reservoir • Spread enhanced if skin is damaged (e.g. burns, eczema, diaper rash)
C. Prober Herpesvirus
Latency
Robert Siegel HSV
Pathophysiology
• Infection following exposure of abraded skin or mucosal surfaces • Penetration of epidermal, dermal, and mucosal epithelial cells • Uptake by cutaneous neurons • Migration to sensory ganglia • Synthesis of infectious virus • Return to inoculation site via peripheral sensory nerves • Destruction of epithelial cells and lesion formation • Establishment of latency in sensory ganglia • Maintenance of latency with periodic reactivation C. Prober
HSV
Epidemiology
• Latency follows all HSV infections, contributing to the ever increasing infectious “pool”
• Approximately 40-90% of children and adolescents are seropositive for HSV-1
• Approximately 15-30% of young adults are seropositive for HSV-2
• Prevalence rates are affected by geographic location, socioeconomic status, race, and age
C. Prober HSV
Pathology
• Infected cells swell, degenerate, and form multinucleated giant cells with intranuclear inclusions
• Local inflammation
• Vesicle formation, if mucocutaneous site
C. Prober Herpes simplex in the suprapubic area John L. Bezzant,M.D. Note the grouped blisters, and the patient experienced severe pain. This was a medical student and he was concerned about the sexual partner from whom he may have contracted this. (His sexual partner was a woman). Epidermis being destroyed by herpes virus infection John L. Bezzant,M.D. Epidermis being destroyed by herpes virus infection. The herpes virus causes essentially complete destruction of the epidermis, and what is seen clinically is a blister, the top of which is formed largely by the very thin stratum corneum. Herpesvirus
Mixing and matching of mucus membranes
Robert Siegel Herpesvirus
HSV-1
Robert Siegel
Keratitis caused by herpes simplex virus Herpesvirus
whitlow
Robert Siegel
HSV encephalitis
HERPESVIRUS HOMINIS GENITAL INFECTION Clinical Case Study
CC: Rash and fever. HPI: CC: Fever, headache and vaginal pain.
History: A nineteen-year-old woman who has recently become sexually active has developed fever, headaches and some dysuria and vulvar pain for the last two days.
Robert Siegel Clinical Case Study
PE: Temp = 38.8°C Resp rate = 14 Heart rate = 90 Blood pressure = 100/70
Robert Siegel Clinical Case Study
PE continued: Positive findings include slight neck stiffness, bilateral tender inguinal lymphadenopathy, and multiple bilateral tender erosions in the vulvar area with few vesicles. The rest of the systemic exam is normal. Labs/radiography: none ordered
Robert Siegel G.O.P.
HSV
Epidemiology
• An estimated 50 million American have genital herpes infection.
Robert Siegel HSV
Transmission
• Most shedding is asymptomatic.
• Most transmission is due to asymptomatic shedding.
• First reactivation may be temporally distant to time of initial infection.
C. Prober Up to 70% of Transmission May Occur During Asymptomatic Viral Shedding
• 9.7% of patients infected their partner (14/144) • Transmission frequently occurs between outbreaks
Transmission during asymptomatic viral shedding Up to 70% ~30%
Transmission during symptomatic outbreaks Mertz GJ, et al. Ann Intern Med. 1992;116:197-202. Neonatal HSV Infection Gravest consequence of gestational HSV Contracted from infected birth canal Risk greatest if maternal primary infection Maximum risk, < 4 weeks of age 3 forms; SEM, Disseminated, CNS 70% untreated mortality rate
Skin, Eye, Mucosal (SEM) Disease
40% of all cases Onset at 1-2 weeks of age Skin lesions and conjunctivitis Importance of rapid diagnosis (DFA) Culture skin lesions / eye discharge Progression if ignored
Disseminated Disease
25% of all cases Onset at < 1 week of age Sepsis, liver failure, respiratory distress Need for high index of suspicion Culture all sites Herpes viruses preferentially spread to the liver, lung, & brain.
Central Nervous System (CNS) Disease
35% of all cases Onset at 2-3 weeks of age Lethargy, irritability, fever, seizures Typical EEG CSF: culture & PCR
Neonatal HSV Infections:Therapy
Outcome depends upon disease type
Type of infection # treated %survival %intact
SEM 85 100% 94% CNS 71 86% 36% Disseminated 46 54% 59%
N Engl J Med 1991;324:444 HSV
Immunity
• Brisk immune response following primary infection
• Antibody reflects prior infection not protection
• Important T-cell factors incompletely defined
C. Prober HSV
Diagnosis
• Tzanck prep (fast, easy, cheap, sensitive) • Antibody seropositive: EIA, LA, etc. (limited utility in determining recent or active infection) • Immunofluorescence • Viral culture – rapid growth, typical CPE • PCR N.B. - Type specific assays based on gG have been developed.
Robert Siegel
Tzanck prep John L. Bezzant,M.D. For a Tzanck prep, the base of the blister is scraped and it is smeared on the slide.
Tzanck prep John L. Bezzant,M.D. The slide is not heated because it would distort the cellular morphology and make it virtually impossible to read the slide. The modified right stain kits come with instructions.
Magnification identifies multinucleated cells John L. Bezzant,M.D. Moderate magnification can be used to identify possible multinucleated giant cells
Multinucleated giant cells John L. Bezzant,M.D. Multinucleated giant cells are very large epidermis cells that have multiple nuclei. Multinucleated giant cells with HSV cervicitis
Diagnosis of HSV Infections
Direct examination for virus: DFA Herpesvirus
Therapy
Robert Siegel HSV
Treatment
• A number of nonpharmacologic interventions for the treatment of recurrent HSV have been suggested. • Placebo effects may produce significant improvement
Robert Siegel HSV
Treatment
• Effective antivirals are available for the treatment and suppression of clinical disease
• Currently licensed antiherpetic drugs are predominant nucleoside analogs that inhibit viral replication by incorporation into the growing nucleotide chain followed by chain termination
Robert Siegel
Molecular biology
Nucleoside analogs • Antivirals • Cancer chemotherapeutics • DNA sequencing
Robert Siegel Treatment Therapeutic index The ratio of the ED50 of a drug to produce a toxic effect to the ED50 to produce a therapeutic effect.
Suppression of lesions
Robert Siegel
HSV
Treatment
Pharmacologic agents used in the treatment of HSV • Acyclovir • Famcyclovir • Valacyclovir • Idoxuridine (ophthalmic) • Trifluridine (ophthalmic) • Vidarabine (Ara-A, cytosine arabinoside – CNS disease)
Robert Siegel
Reduction in the Risk of Transmission
TREAT HIM
PROTECT HER
Please consult complete Prescribing Information for VALTREX. HSV
Prevention
• Barrier methods are very important in reducing transmission. • Ceasarian section decreases transmission to the newborn in primary infections of the mom. • Acyclovir is used for secondary prevention.
Robert Siegel HSV
Vaccination
• There is no currently licensed vaccine for HSV-1 or HSV-2. • There are numerous of vaccine candidates currently under investigation. • A number of vaccines have reached human clinical trials. • A number of vaccine candidates focus on envelope glycoprotein gG. • DNA vaccines are a promising line of investigation.
Robert Siegel HSV
Vaccination
• gD2 subunit with AS04 adjuvant; GSK/NIH; in Phase III
• live attenuated ICP8 DISC virus vaccine; Xenova; Phase I/II
• other live attenuated, replication-competent virus vaccines; Avant (Phase I); AuRix (Phase II)
Robert Siegel
VZV (varicella-zoster virus)
Going down the zoster roster
Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6A and B) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel Varicella Zoster Virus Classification
• Family: Herpesviridae • Subfamily: Alphaherpesvirus • Agent: Varicella Zoster Virus (VZV) • ICD-10 B01-B02 (ICD-9 052-053) • Reservoir: humans
Robert Siegel
Pox terminology
• Pox • Smallpox • Great pox • Chickenpox
Robert Siegel VZV terminology
• Chickenpox • Varicella • Shingles • Zoster
Robert Siegel Virology MAJOR ROUTES OF VIRAL TRANSMISSION
• RESPIRATORY • FECAL-ORAL • DIRECT CONTACT • SEXUAL • PARENTERAL • ARBO (arthropod-borne) • VERTICAL (Intrauterine, Perinatal, Breast Milk) • FOMITE
Robert Siegel VZV
Transmission
• Respiratory droplets
• Highly contagious
Robert Siegel VZV
Epidemiology
• Young children
Robert Siegel VZV
Epidemiology
• Young children
• Highly seasonal
Robert Siegel
VZV
Epidemiology
• Young children
• Highly seasonal
• Highly species specific
Robert Siegel VZV Pathogenesis
• Respiratory transmission
• Initial replication in oral pharynx
• Hematologic dissemination
• Development of acute disease
• Latency in sensory ganglia
• Reactivation
Robert Siegel
VZV Pathology
• Characteristic CPE
• Viral inclusion bodies (nuclear)
• Multinucleated giant cells
• Vesicular lesions are filled with virus
Robert Siegel
Clinical features
Chickenpox Primary infection
Robert Siegel Viral exanthems
Classification
• Erythematous maculo-papular • Vesicular • Nonerythematous papular • Other (petechial, pustular, etc.)
Robert Siegel VZV
Clinical features
• Highly contagious
• Low pathogenicity
• Successive waves of lesions
• More severe in adults
Robert Siegel
Herpesvirus
Complications • Scarring
Robert Siegel Herpesvirus
Complications • Scarring Early lesions? Secondary infection? Stochastic?
Robert Siegel
Herpesvirus
Complications • Scarring • Reactivation
Robert Siegel Herpesvirus
Zoster
Robert Siegel
Herpesvirus
Complications • Scarring • Reactivation post herpetic neuralgia
Robert Siegel Herpesvirus
Complications • Scarring • Reactivation • Varicella pneumonia
Robert Siegel
Herpesvirus
Complications • Scarring • Reactivation • Varicella pneumonia Most severe in pregnant women
Robert Siegel
Complications of VZV infection - I
• Varicella pneumonia (esp in pregnancy) • Encephalitis • Bacterial super infection (including necrotizing fasciitis) • Aseptic meningitis • Myocarditis
Robert Siegel
Complications of VZV infection - II
• Glomerulonephritis • Purpura fulminans • Reye’s syndrome • Transverse myelitis • Congenital malformation
Robert Siegel Herpesvirus
Complications • Scarring • Reactivation • Varicella pneumonia • Reyes syndrome
Robert Siegel Reye’s syndrome • Hepatoencephalopathy • Sudden onset, vomiting, lethargy • Pediatric generally 5-16 • Associated with VZV and influenza in convalescent period • High mortality (20-30%) • High morbidity (60% permanent neurological or psychological damage) • Rare • Increased risk with use of salicylates
Herpesvirus
Complications • Scarring • Reactivation • Varicella pneumonia • Reyes syndrome • Secondary infection Robert Siegel VZV
Treatment
Pharmacologic agents used in the treatment of VZV • Acyclovir • Famcyclovir • Valacyclovir
Robert Siegel Prevention of Viral Disease
Medical • Active immunoprophylaxis - vaccination • Passive immunoprophylaxis - antibody administration • Prophylatic antiviral medication
Robert Siegel Herpesvirus
Vaccination
Robert Siegel
Vaccination
Varicella zoster virus
Varivax • Live, attenuated
• Oka strain
• Licensed 1995
• Merck
Robert Siegel Attenuateda Host range mutantb Temperature sensitive mutant Cold adapted mutant Deletion mutant Live Recombinantc
Virulentd
Virion
Anti-idiotype Inactivated Purified Synthetic Proteine “Cloned”f
Varicella zoster virus
Zostavax Vaccine now approved for suppression of shingles
Robert Siegel Varicella zoster virus
VZIG
Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6a, HHV-6b) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel •
HHV6a, HHV6b, HHV7 Herpesvirus
• Family: Herpesviridae • Subfamily: Betaherpesvirinae
• Genus: Roseolovirus (3) • Agents: HHV-6a, HHV-6b, HHV-7 • ICD-10 B08.2 (ICD-9 057.8) • Reservoir: humans • Infect CD4+ T-cells
Robert Siegel •
HHV-6a, HHV-6b, HHV-7 Clinical
Disease associations • Roseola (HHV-6b, HHV-7) • Synonyms: Roseola subitum, Roseola infantum, Exanthem subitum, Sixth disease
Robert Siegel Herpesvirus
Roseola
Robert Siegel FILATOV CLASSIFICATION Viral Exanthems
RED RASHES OF CHILDHOOD
1) MEASLES (paramyxovirus: rubeola) 2) SCARLATINA (bacteria: streptococcus) 3) RUBELLA (togavirus: rubella) 4) SCARLATINOID (???) 5) ERYTHEMA INFECTIOSUM (parvovirus: B-19) 6) ROSEOLA SUBITIUM (herpesvirus: HHV-6)
Robert Siegel FILATOV CLASSIFICATION Viral Exanthems
VIRAL RED RASHES OF CHILDHOOD
1) MEASLES (paramyxovirus: rubeola) 2) RUBELLA (togavirus: rubella) 3) ERYTHEMA INFECTIOSUM (parvovirus: B-19) 4) ROSEOLA SUBITIUM (herpesvirus: HHV-6) 5) ENTEROVIRAL RASHES (picornavirus: enteroviruses)
Robert Siegel
Erythematous Viral Exanthems: Common Themes
• Lesions generally do not contain virus • Rash is immunological response • Viremic phase • Period of maximal infectivity usually precedes rash. • Enduring immunity • Prevalence in childhood
Robert Siegel Roseola Clinical
• Incubation period 10 days (range 5-15) slightly longer in transplant recipients • Acute febrile illness • Very high fever - as high as 41oC (106oF) • Association with febrile seizures • Duration of fever: 3-5 days • Evanescent maculopapular exanthem in post-febrile phase
Robert Siegel Roseola Epidemiology
• World-wide distribution • Peak incidence: 6-12 months of age • Most children are seropositive by age 2
Robert Siegel Roseola Transmission
• Asymptomatic shedding from the salivary glands may occur throughout life • Contact with saliva is believed to be an important route of transmission • Virus may be transmitted by kidney or liver transplantation
Robert Siegel
Roseola Management
• There are no licensed treatments. • There are no licensed vaccines or promising vaccine candidates
Robert Siegel Recurrent Aphthous Ulcers (RAU) Clinical Etiology unknown
Robert Siegel The hypothesisThe ofhypothesis Drs. Robert of Drs.D. Siegel Robert D. Siegel and Reubenand Granich Reuben that Granich recurrent that recurrent aphthous ulcersaphthous (RAU) ulcers are a (RAU)clinical are a clinical manifestationmanifestation of human herpesvirus of human herpesvirus 6 6 (HHV6) reactivation(HHV6) reactivationis intriguing is and intriguing and should be tested.should be tested.
OralOral Surgery, Surgery, Oral Oral Medicine, Medicine, OralOral Pathology Pathology VolVol 76, 76, Number Number 4, 4, 406 406
Herpesviruses
KSHV
Robert Siegel The Eight Human HERPESVIRUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel •
HHV-8 Etiology
• Family: Herpesviridae • Subfamily: Gammaherpesvirinae
• Genus: Rhadinovirus (2) • Synonyms: Kaposi’s sarcoma associated herpesvirus, (KSHV) • Discovered in 1994 (Chang et al.) • Contain immune modulating proteins
Robert Siegel KSHV Historical
• Isolation by Chang and Moore (1994) • Representational difference analysis (RDA) • 2000 articles
Robert Siegel KSHV Epidemiology
• 33% homosexual males • 8% HIV neg patients attending STD clinics • 3% blood donors (HIV negative)
Robert Siegel KSHV Clinical Clinical disease associations: • Primary infection – none characterized • Secondary infection – none characterized • Oncogenic associations – KS and others • Most infections in immunocompetent individuals are asymptomatic
Robert Siegel Virology Viruses associated with HUMAN CANCER: • Human T-cell lymphotropic virus type I (HTLV-1) • Epstein-Barr virus (EBV) • Human papilloma virus (HPV) • Hepatitis B virus (HBV) • Hepatitis C virus (HCV) • Kaposi’s sarcoma associated herpes (KSHV)
Robert Siegel KSHV Clinical Oncogenic associations: • Kaposi’s sarcoma (KS) • Primary effusion lymphoma (PEL) – rare form of B- cell lymphoma • Multicentric Castleman’s disease (MCD) - plasma cell variant Non-oncogenic associations: • Primary pulmonary hypertension (2003) Robert Siegel •
Kaposi’s sarcoma Epidemiology
• HIV associated KS • African endemic KS • “Classic” Mediterranean KS • Post-transplant KS
Robert Siegel •
Kaposi’s sarcoma Epidemiology
• Reservoir: humans • Second leading cause of death in HIV infected individuals (U.S.)
Robert Siegel •
Kaposi’s sarcoma Pathology
• Endothelial tumors • Characteristic KS spindle cells • KSHV DNA detected in spindle cells as site of latent infection • KSHV association found in all forms of KS • Cofactors for progression: immunodeficiency, others (unknown)
Robert Siegel
•
Primary effusion lymphoma (PEL) Clinical
• Body cavity-based lymphoma • Rare form of B-cell lymphoma
Robert Siegel •
Plasma cell variant of multicentric Castleman’s disease (MCD) Clinical • Hyperplastic B-cell lymphoproliferative disorder • HIV associated
Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6A and B) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel The Eight Human HERPESVIRSUS Virology
• Herpes simplex virus 1 (HSV-1) • Herpes simplex virus 2 (HSV-2) • Varicella-zoster virus (VZV) • Epstein-Barr virus (EBV) • Cytomegalovirus (CMV) • Human herpes virus 6 (HHV-6A and B) • Human herpes virus 7 (HHV-7) • Human herpes virus 8 (HHV-8, KSHV) Robert Siegel The Eight Human HERPESVIRSUS +1 Virology
Herpes B virus a zoonosis may result in a highly fatal meningoencephalitis
Robert Siegel B-virus Virology
Synonyms: • Cercopithecine herpes virus 1 • Simian B virus • Herpes simiae • B virus Taxonomy • Alphaherpesvirus • Closely related to HSV Robert Siegel
B-virus Epidemiology Direct contact with Old-World monkeys • Veterinarians • Researchers
Robert Siegel